Navigation Links
Thermostable dUTPase from GenScript Corporation

ProductsThermostable dUTPase from GenScript Corporation
Company GenScript Corporation
Item Thermostable dUTPase
Price $550.00
Description Thermostable dUTPase
The thermostable dUTPase(pyrococcus fruriosus) maximizes the efficiency of high-fidelity PCR (using proofreading DNA polymerases). It removes contaminating dUTP present in PCR reactions and dNTP solutions. The presence of dUTPase in a proofreading DNA polymerase reaction can prevent dUTP misincorporation by maintaining dUTP levels below their inhibitory concentrations despite the constant generation of the molecule by the spontaneous deamination of dCTP. The incorporation of dUTP into PCR products causes mutations within the amplified product, proofreading polymerases to stall and slows down non-proofreading polymerases such as Taq. The dUTPase increase in PCR product yield, length and fidelity enables further down-stream applications. These effects make dUTPase useful in PCR fidelity and yield-sensitive applications such as cloning and subsequent recombinant protein technology, and gene expression analysis (semi-quantitative RT-PCR techniques and real-time PCR analysis), where small differences in product accumulation can have a significant impact on gene expression analysis. dUTPase is specific for dUTP and is critical for the fidelity of DNA replication and repair. dUTPase hydrolyzes dUTP to dUMP and pyrophosphate, simultaneously reducing dUTP levels and providing the dUMP for dTTP biosynthesis.
Info GenScript CorporationGenScript Corporation
120 Centennial Ave.
Piscataway, NJ 08854
USA

Customer Service: (Toll Free) : (877) 436-7274
(732) 885-9188
(732) 885-9688
Fax Number: (732) 210-0262
(732) 885-587
Web Site: http://www.genscript.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Expand High Fidelity PLUS PCR System; Thermostable DNA polymerase mixture from Roche Applied Science
2. Expand 20 kb PLUS PCR System; Thermostable DNA polymerase mixture from Roche Applied Science
3. Mouse Anti-Nop1p / Fibrillarin Monoclonal Antibody, Unconjugated, Clone A00104.01 from GenScript Corporation
4. GCpro Taq DNA Polymerase Complete System from GenScript Corporation
5. Coating Stabilizer from GenScript Corporation
6. Lyophilization Stabilizer from GenScript Corporation
7. Lyophilization Stabilizer from GenScript Corporation
8. Agarose Gel Loading Dye Mixture 6X (with ficoll) from GenScript Corporation
9. Agarose Gel Loading Dye Mixture 6X from GenScript Corporation
10. Full-Configuration Camera Link NI PCIe-1429 from National Instruments Corporation
11. pMIR-mU6-Luc, Mouse U6 Luciferase Control Vector from Mirus Bio Corporation
(Date:1/11/2016)... SAN JOSE, Calif. , Jan. 11, 2016 /PRNewswire/ ... developer of human interface solutions, today announced that its ... display driver integration (TDDI) products won two separate categories ... including Best Mobile Innovator and Best Technology Breakthrough. The ... overall system cost, a simplified supply chain, thinner devices, ...
(Date:1/8/2016)... MANCHESTER, United Kingdom , Jan. 8, 2016 ... innovative sensor-based diagnostic products, today announced the closing of a ... existing investors.  Proceeds from the financing will be used to ... hand-held device for detecting early-stage pressure ulcers. ... after receiving CE Mark approval. The device,s introduction has ...
(Date:1/7/2016)... NEW YORK , Jan. 7, 2016 ... as regional markets for biometric technologies and devices, identifying ... application market for various types of biometric devices. Includes ... report to: Identify newer markets and explore the ... of biometric devices. Examine each type of biometric technology, ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today that Edward Lanphier , Sangamo,s president and ... progress of Sangamo,s ZFP Therapeutic ® development programs ... 2:40 pm ET on Thursday, February 11, 2016, at ... Conference. The conference is being held in ...
(Date:2/4/2016)... VANCOUVER, British Columbia and MENLO PARK, ... Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical ... therapies, today announced that it will present at the ... on Monday, February 8, 2016 at 10:00 a.m. EST in ... Jeffrey Bacha , DelMar,s president and CEO, will provide an ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... of Semantic Graph Database technology has been recognized As “ Best in Semantic ... America Magazine. , “At Corporate America, it’s our priority to showcase prominent professionals ...
(Date:2/3/2016)... 3, 2016  With the growing need for ... is underway, therapies such as monoclonal antibodies, recombinant ... host of indications are in high demand. Conventionally ... development and production of these therapeutics. However, due ... high costs, novel approaches and novel expression systems ...
Breaking Biology Technology: